Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,083 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Noncanonical WNT5A controls the activation of latent TGF-β to drive fibroblast activation and tissue fibrosis.
Trinh-Minh T, Chen CW, Tran Manh C, Li YN, Zhu H, Zhou X, Chakraborty D, Zhang Y, Rauber S, Dees C, Lin NY, Kah D, Gerum R, Bergmann C, Kreuter A, Reuter C, Groeber-Becker F, Eckes B, Distler O, Fabry B, Ramming A, Schambony A, Schett G, Distler JH. Trinh-Minh T, et al. Among authors: schett g. J Clin Invest. 2024 Mar 26;134(10):e159884. doi: 10.1172/JCI159884. J Clin Invest. 2024. PMID: 38747285 Free PMC article.
68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study.
Bergmann C, Distler JHW, Treutlein C, Tascilar K, Müller AT, Atzinger A, Matei AE, Knitza J, Györfi AH, Lück A, Dees C, Soare A, Ramming A, Schönau V, Distler O, Prante O, Ritt P, Götz TI, Köhner M, Cordes M, Bäuerle T, Kuwert T, Schett G, Schmidkonz C. Bergmann C, et al. Among authors: schett g. Lancet Rheumatol. 2021 Mar;3(3):e185-e194. doi: 10.1016/S2665-9913(20)30421-5. Epub 2021 Jan 25. Lancet Rheumatol. 2021. PMID: 38279381
CD200+ fibroblasts form a pro-resolving mesenchymal network in arthritis.
Rauber S, Mohammadian H, Schmidkonz C, Atzinger A, Soare A, Treutlein C, Kemble S, Mahony CB, Geisthoff M, Angeli MR, Raimondo MG, Xu C, Yang KT, Lu L, Labinsky H, Saad MSA, Gwellem CA, Chang J, Huang K, Kampylafka E, Knitza J, Bilyy R, Distler JHW, Hanlon MM, Fearon U, Veale DJ, Roemer FW, Bäuerle T, Maric HM, Maschauer S, Ekici AB, Buckley CD, Croft AP, Kuwert T, Prante O, Cañete JD, Schett G, Ramming A. Rauber S, et al. Among authors: schett g. Nat Immunol. 2024 Apr;25(4):682-692. doi: 10.1038/s41590-024-01774-4. Epub 2024 Feb 23. Nat Immunol. 2024. PMID: 38396288
Characterization of Vascular Niche in Systemic Sclerosis by Spatial Proteomics.
Rius Rigau A, Li YN, Matei AE, Györfi AH, Bruch PM, Koziel S, Devakumar V, Gabrielli A, Kreuter A, Wang J, Dietrich S, Schett G, Distler JHW, Liang M. Rius Rigau A, et al. Among authors: schett g. Circ Res. 2024 Mar 29;134(7):875-891. doi: 10.1161/CIRCRESAHA.123.323299. Epub 2024 Mar 5. Circ Res. 2024. PMID: 38440901 Free article.
BCMA-Targeted T-Cell-Engager Therapy for Autoimmune Disease.
Hagen M, Bucci L, Böltz S, Nöthling DM, Rothe T, Anoshkin K, Raimondo MG, Tur C, Wirsching A, Wacker J, Düsing C, Distler JHW, Kuwert T, Bozec A, Ramming A, Schett G, Grieshaber-Bouyer R. Hagen M, et al. Among authors: schett g. N Engl J Med. 2024 Sep 5;391(9):867-869. doi: 10.1056/NEJMc2408786. N Engl J Med. 2024. PMID: 39231353 No abstract available.
CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series.
Auth J, Müller F, Völkl S, Bayerl N, Distler JHW, Tur C, Raimondo MG, Chenguiti Fakhouri S, Atzinger A, Coppers B, Eckstein M, Liphardt AM, Bäuerle T, Tascilar K, Aigner M, Kretschmann S, Wirsching A, Taubmann J, Hagen M, Györfi AH, Kharboutli S, Krickau T, Dees C, Spörl S, Rothe T, Harrer T, Bozec A, Grieshaber-Bouyer R, Fuchs F, Kuwert T, Berking C, Horch RE, Uder M, Mackensen A, Schett G, Bergmann C. Auth J, et al. Among authors: schett g. Lancet Rheumatol. 2024 Nov 11:S2665-9913(24)00282-0. doi: 10.1016/S2665-9913(24)00282-0. Online ahead of print. Lancet Rheumatol. 2024. PMID: 39542003 Free article.
Combination therapies of porcupine inhibition with ruxolitinib, ibrutinib or belumosudil in murine sclerodermatous GvHD.
Hong X, Xiao Y, Xu L, Shen L, Neelagar R, Devakumar V, Trinh-Minh T, Liang M, Rius Rigau A, Zhang Y, Li YN, Dees C, Györfi AH, Wolff D, Herr W, Schett G, Distler JHW, Matei AE. Hong X, et al. Among authors: schett g. Blood Adv. 2025 Jan 7:bloodadvances.2024014387. doi: 10.1182/bloodadvances.2024014387. Online ahead of print. Blood Adv. 2025. PMID: 39775728 No abstract available.
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study.
Elhai M, Avouac J, Walker UA, Matucci-Cerinic M, Riemekasten G, Airò P, Hachulla E, Valentini G, Carreira PE, Cozzi F, Balbir Gurman A, Braun-Moscovici Y, Damjanov N, Ananieva LP, Scorza R, Jimenez S, Busquets J, Li M, Müller-Ladner U, Kahan A, Distler O, Allanore Y; EUSTAR co-authors. Elhai M, et al. Ann Rheum Dis. 2016 Jan;75(1):163-9. doi: 10.1136/annrheumdis-2014-206386. Epub 2014 Oct 23. Ann Rheum Dis. 2016. PMID: 25342760
1,083 results